Stanford research shows that nearly one in 20 reproductive-age women have depression and less than one-third are taking antidepressants.
Clinicians now have up to 24 hours to treat a stroke, thanks in part to research and tools developed at Stanford Medicine.
A new Clinical Genomics Program at Stanford will improve the diagnosis of rare genetic diseases, benefiting patients such as Tessa and Colton Nye.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Stanford anesthesiologist and writer Audrey Shafer reflects on the importance of considering the scientific and ethical issues raised by Frankenstein.
Stanford Storybank, organized by Stanford Health Care, collects 40-minute audio stories from patients and members of the Stanford Medicine community.
Stanford pediatric cardiologist Seth Hollander comments on Shaun White's success, and explains the condition called tetralogy of Fallot.
The key to preventing dangerous Aspergillus fumigatus infections following lung transplant may be blocking iron, a new Stanford Medicine study has found.
A look at the lab and work of Brian Kobilka, who won the 2012 Nobel Prize in Chemistry.
Stanford orthopedic surgeon Eugene Roh is serving as a Team USA physician during the Winter Olympics in South Korea.
"We have the opportunity to lead in meeting the needs and affirming the value and importance of our LGBTQ community," Dean Lloyd Minor said at campus event.
Stanford chemist Lynette Cegelski and her team discovered a new form of bacterial cellulose, a finding that could shed light on new ways to fight bacterial infections.
Stanford's Leah Backhus cofounded the Artemis Medical Society to support women and girls of color who are interested in medical careers.
A Stanford and VA team investigated how health care systems affect care given at the end of life.
A woman with a rare genetic eye disease called neovascular inflammatory vitreoretinopathy, or NIV, shares her story.
By identifying abnormally expressed proteins in the eye, a Stanford-led team matched existing drugs with these proteins to quell patients' symptoms.